Pegfilgrastim (pegylated granulocyte colony-stimulating factor, PEG-G-CSF) is routinely used as prophylaxis for febrile neutropenia (FN) during chemotherapy regimens for breast cancer at high risk of causing FN. Here, CSF3 is linked to breast carcinoma.